Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

Written By Guest User

by: Research News @ Vanderbilt University

Guest User
Previous

New Dystonia Drug Candidates Discovered
Next

Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.